Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis

Schizophrenia Research

Volumn 125, Issue 1, 2011, Pages 1-12

  Trzesniak, Clarissa ^a,b   Oliveira, Irismar R ^c   Kempton, Matthew J ^b   Galvão de Almeida, Amanda ^c,d   Chagas, Marcos H N ^a   Ferrari, Maria Cecília F ^a   Filho, Alaor S ^a   Zuardi, Antonio W ^a   Prado, Daniel A ^a   Busatto, Geraldo F ^a   McGuire, Phillip K ^b   Hallak, Jaime E C ^a   Crippa, José Alexandre S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cavum septum pellucidum; Magnetic resonance imaging; Meta analysis; Schizophrenia

Indexed keywords

ANATOMICAL VARIATION; BRAIN MALFORMATION; HUMAN; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SEPTUM PELLUCIDUM; SYSTEMATIC REVIEW;

DATABASES, FACTUAL; HUMANS; MAGNETIC RESONANCE IMAGING; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SEPTUM PELLUCIDUM;

EID: 78650309370     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.09.016     Document Type: Review

References (63)

1. Aviv R.I., Tomlinson G., Kendall B., Thakkar C., Valentine A. Cavum septi pellucidi in boxers. Can. Assoc. Radiol. J. 2010, 61(1):29-32.
2. Borenstein, M., Hedges, L., Higgins, J., Rothstein, H., 2009. Comprehensive meta-analysis. Available at: http://www.meta-analysis.com/.
3. Brown A.S., Deicken R.F., Vinogradov S., Kremen W.S., Poole J.H., Penner J.D., Kochetkova A., Kern D., Schaefer C.A. Prenatal infection and cavum septum pellucidum in adult schizophrenia. Schizophr. Res. 2009, 108:285-287.
4. Cannon T.D., van Erp T.G., Bearden C.E., Loewy R., Thompson P., Toga A.W., Huttunen M.O., Keshavan M.S., Seidman L.J., Tsuang M.T. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr. Bull. 2003, 29(4):653-669.
5. Chakos M.H., Schobel S.A., Gu H., Gerig G., Bradford D., Charles C., Lieberman J.A. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br. J. Psychiatry 2005, 186:26-31.
6. Choi J.S., Kang D.H., Park J.Y., Jung W.H., Choi C.H., Chon M.W., Jung M.H., Lee J.M., Kwon J.S. Cavum septum pellucidum in subjects at ultra-high risk for psychosis: compared with first-degree relatives of patients with schizophrenia and healthy volunteers. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(5):1326-1330.
7. Crippa J.A., Uchida R., Busatto G.F., Guimarães F.S., Del-Ben C.M., Zuardi A.W., Santos A.C., Araújo D., McGuire P.K., Graeff F.G. The size and prevalence of the cavum septum pellucidum are normal in subjects with panic disorder. Braz. J. Med. Biol. Res. 2004, 37(3):371-374.
8. Crippa J.A., Waldo Zuardi A., Trzesniak C., Hallak J.E., Busatto G.F., McGuire P.K. No association between electrodermal hyporesponsivity and enlarged cavum septi pellucidi in schizophrenia. Schizophr. Res. 2007, 95(1-3):256-258.
9. de Souza Crippa J.A., Zuardi A.W., Busatto G.F., Sanches R.F., Santos A.C., Araújo D., Amaro E., Hallak J.E., Ng V., McGuire P.K. Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. Eur. Psychiatry 2006, 21(5):291-299.
10. Degreef G., Bogerts B., Falkai P., Greve B., Lantos G., Ashtari M., Lieberman J. Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res. 1992, 45(1):1-13.
11. Degreef G., Lantos G., Bogerts B., Ashtari M., Lieberman J. Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am. J. Neuroradiol. 1992, 13(3):835-840.
12. DeLisi L.E. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?. Schizophr. Res. 1997, 23(2):119-129.
13. DeLisi L.E., Hoff A.L., Kushner M., Degreef G. Increased prevalence of cavum septum pellucidum in schizophrenia. Psychiatry Res. 1993, 50(3):193-199.
14. Dickey C.C., McCarley R.W., Xu M.L., Seidman L.J., Voglmaier M.M., Niznikiewicz M.A., Connor E., Shenton M.E. MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder. Schizophr. Res. 2007, 89:49-58.
15. Dwan K., Altman D.G., Arnaiz J.A., Bloom J., Chan A.W., Cronin E., Decullier E., Easterbrook P.J., Von Elm E., Gamble C., Ghersi D., Ioannidis J.P., Simes J., Williamson P.R. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 2008, 28(3):e3081. (8).
16. Egger M., Davey Smith G., Schneider M., Minder C. Bias in metaanalysis detected by a simple, graphical test. Bmj 1997, 315(7109):629-634.
17. Ellison-Wright I., Glahn D.C., Laird A.R., Thelen S.M., Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am. J. Psychiatry 2008, 165(8):1015-1023.
18. Filipović B., KovaceviĆ S., StojiciĆ M., Prostran M., FilipoviĆ B. Morphological differences among cavum septi pellucidi obtained in patients with schizophrenia and healthy individuals: forensic implications. A post-mortem study. Psychiatry Clin. Neurosci. 2005, 59(1):106-108.
19. Flashman L.A., Roth R.M., Pixley H.S., Cleavinger H.B., McAllister T.W., Vidaver R., Saykin A.J. Cavum septum pellucidum in schizophrenia: clinical and neuropsychological correlates. Psychiatry Res. 2007, 154(2):147-155.
20. Fukuzako H., Kodama S. Cavum septum pellucidum in schizophrenia. Biol. Psychiatry 1998, 43(6):467.
21. Fukuzako T., Fukuzako H., Kodama S., Hashiguchi T., Takigawa M. Cavum septum pellucidum in schizophrenia: a magnetic resonance imaging study. Psychiatry Clin. Neurosci. 1996, 50(3):125-128.
22. Galarza M., Merlo A.B., Ingratta A., Albanese E.F., Albanese A.M. Cavum septum pellucidum and its increased prevalence in schizophrenia: a neuroembryological classification. J. Neuropsychiatry Clin. Neurosci. 2004, 16(1):41-46.
23. Girgis R.R., Diwadkar V.A., Nutche J.J., Sweeney J.A., Keshavan M.S., Hardan A.Y. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr. Res. 2006, 82(1):89-94.
24. Hagino H., Suzuki M., Kurokawa K., Mori K., Nohara S., Takahashi T., Yamashita I., Yotsutsuji T., Kurachi M., Seto H. Magnetic resonance imaging study of the cavum septi pellucidi in patients with schizophrenia. Am. J. Psychiatry 2001, 158(10):1717-1719.
25. Hallak J.E., Crippa J.A., Pinto J.P., Machado de Sousa J.P., Trzesniak C., Dursun S.M., McGuire P., Deakin J.F., Zuardi A.W. Total agenesis of the corpus callosum in a patient with childhood-onset schizophrenia. Arq. Neuropsiquiatr. 2007, 65(4B):1216-1219.
26. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10(1):40-68. (image 5).
27. Jurjus G.J., Nasrallah H.A., Olson S.C., Schwarzkopf S.B. Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study. Psychol. Med. 1993, 23(2):319-322.
28. Kasai K., McCarley R.W., Salisbury D.F., Onitsuka T., Demeo S., Yurgelun-Todd D., Kikinis R., Jolesz F.A., Shenton M.E. Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study. Schizophr. Res. 2004, 71(1):65-76.
29. Kempton M.J., Stahl D., Williams S.C., DeLisi L.E. Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies. Schizophr. Res. 2010, 120(1-3):54-62.
30. Keshavan M.S., Jayakumar P.N., Diwadkar V.A., Singh A. Cavum septi pellucidi in first-episode patients and young relatives at risk for schizophrenia. CNS Spectr. 2002, 7(2):155-158.
31. Kuloglu M., Caykoylu A., Yilmaz E., Ekinci O. A left temporal lobe arachnoid cyst in a patient with schizophrenia-like psychosis: a case report. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(5):1353-1354.
32. Kwon J.S., Shenton M.E., Hirayasu Y., Salisbury D.F., Fischer I.A., Dickey C.C., Yurgelun-Todd D., Tohen M., Kikinis R., Jolesz F.A., McCarley R.W. MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am. J. Psychiatry 1998, 155(4):509-515.
33. Lim J.J., Yoon S.H. The first neurosurgical analysis of 8 Korean children with Sotos syndrome. J. Korean Neurosurg. Soc. 2008, 44(4):240-244.
34. McClure R.K., Phillips I., Jazayerli R., Barnett A., Coppola R., Weinberger D.R. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res. 2006, 148(2-3):121-132.
35. Meisenzahl E.M., Koutsouleris N., Bottlender R., Scheuerecker J., Jäger M., Teipel S.J., Holzinger S., Frodl T., Preuss U., Schmitt G., Burgermeister B., Reiser M., Born C., Möller H.J. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr. Res. 2008, 104(1-3):44-60.
36. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. Brit. Med. J. 1987, 295(6600):681-682.
37. Naylor C.D. Meta-analysis and the meta-epidemiology of clinical research. Br. Med. J. 1997, 315:617-619.
38. Nopoulos P., Swayze V., Andreasen N.C. Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi. J. Neuropsychiatry Clin. Neurosci. 1996, 8(2):147-152.
39. Nopoulos P., Swayze V., Flaum M., Ehrhardt J.C., Yuh W.T., Andreasen N.C. Cavum septi pellucidi in normals and patients with schizophrenia as detected by magnetic resonance imaging. Biol. Psychiatry 1997, 41(11):1102-1108.
40. Nopoulos P.C., Giedd J.N., Andreasen N.C., Rapoport J.L. Frequency and severity of enlarged cavum septi pellucidi in childhood-onset schizophrenia. Am. J. Psychiatry 1998, 155(8):1074-1079.
41. Nopoulos P., Krie A., Andreasen N.C. Enlarged cavum septi pellucidi in patients with schizophrenia: clinical and cognitive correlates. J. Neuropsychiatry Clin. Neurosci. 2000, 12(3):344-349.
42. Pantelis C., Yücel M., Wood S.J., McGorry P.D., Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust. N.Z.J. Psychiatry 2003, 37(4):399-406.
43. Pantelis C., Yücel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull. 2005, 31(3):672-696.
44. Pratt H.D. Neurodevelopmental issues in the assessment and treatment of deficits in attention, cognition, and learning during adolescence. Adolesc. Med. 2002, 13(3):579-598.
45. Rajarethinam R., Miedler J., DeQuardo J., Smet C.I., Brunberg J., Kirbat R., Tandon R. Prevalence of cavum septum pellucidum in schizophrenia studied with MRI. Schizophr. Res. 2001, 48(2-3):201-205.
46. Rajarethinam R., Sohi J., Arfken C., Keshavan M.S. No difference in the prevalence of cavum septum pellucidum (CSP) between first-episode schizophrenia patients, offspring of schizophrenia patients and healthy controls. Schizophr. Res. 2008, 103(1-3):22-25.
47. Rakic P., Yakovlev P.I. Development of the corpus callosum and cavum septi in man. J. Comp. Neurol. 1968, 132(1):45-72.
48. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 2005, 10(5):434-449.
49. Renier D., Arnaud E., Cinalli G., Sebag G., Zerah M., Marchac D. Prognosis for mental function in Apert's syndrome. J. Neurosurg. 1996, 85(1):66-72.
50. Sarwar M. The septum pellucidum: normal and abnormal. Am. J. Neuroradiol. 1989, 10(5):989-1005.
51. Schaefer G.B., Bodensteiner J.B., Buehler B.A., Lin A., Cole T.R. The neuroimaging findings in Sotos syndrome. Am. J. Med. Genet. 1997, 68(4):462-465.
52. Scott T.F., Price T.R., George M.S., Brillman J., Rothfus W. Midline cerebral malformations and schizophrenia. J. Neuropsychiatry Clin. Neurosci. 1993, 5(3):287-293.
53. Shaw C.M., Alvord E.C. Cava septi pellucidi et vergae: their normal and pathogical states. Brain 1969, 92(1):213-223.
54. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49(1-2):1-52.
55. Shioiri T., Oshitani Y., Kato T., Murashita J., Hamakawa H., Inubushi T., Nagata T., Takahashi S. Prevalence of cavum septum pellucidum detected by MRI in patients with bipolar disorder, major depression and schizophrenia. Psychol. Med. 1996, 26(2):431-434.
56. Shunk H. Congenital dilatations of the septi pellucidum. Radiology 1963, 81:610-618.
57. Swayze V.W., Johnson V.P., Hanson J.W., Piven J., Sato Y., Giedd J.N., Mosnik D., Andreasen N.C. Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 1997, 99(2):232-240.
58. Takahashi T., Suzuki M., Hagino H., Niu L., Zhou S.Y., Nakamura K., Tanino R., Kawasaki Y., Seto H., Kurachi M. Prevalence of large cavum septi pellucidi and its relation to the medial temporal lobe structures in schizophrenia spectrum. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31(6):1235-1241.
59. Takahashi T., Yung A.R., Yücel M., Wood S.J., Phillips L.J., Harding I.H., Soulsby B., McGorry P.D., Suzuki M., Velakoulis D., Pantelis C. Prevalence of large cavum septi pellucidi in ultra high-risk individuals and patients with psychotic disorders. Schizophr. Res. 2008, 105(1-3):236-244.
60. Thompson S.G., Smith T.C., Sharp S.J. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat. Med. 1997, 16:2741-2758.
61. Uematsu M., Kaiya H. Midsagittal cortical pathomorphology of schizophrenia: a magnetic resonance imaging study. Psychiatry Res. 1989, 30(1):11-20.
62. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44(7):660-669.
63. Zhang L., Ravdin L.D., Relkin N., Zimmerman R.D., Jordan B., Lathan W.E., Ulu? A.M Increased diffusion in the brain of professional boxers: a preclinical sign of traumatic brain injury?. AJNR Am. J. Neuroradiol. 2003, 24(1):52-57.